4//SEC Filing
Engle James R 4
Accession 0001225208-10-026148
CIK 0001405197other
Filed
Dec 1, 7:00 PM ET
Accepted
Dec 2, 4:09 PM ET
Size
9.0 KB
Accession
0001225208-10-026148
Insider Transaction Report
Form 4
Engle James R
Sr. VP, Information Technology
Transactions
- Exercise/Conversion
Options (right to buy)
2010-12-01$1.39/sh−27,408$38,097→ 28,464 totalExercise: $1.39From: 2006-04-01Exp: 2015-11-10→ Common Stock (27,408 underlying) - Exercise/Conversion
Common Stock
2010-12-01$1.39/sh+27,408$38,097→ 30,039 total - Sale
Common Stock
2010-12-01$21.50/sh−27,408$589,272→ 2,631 total
Footnotes (3)
- [F1]The transaction reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 24, 2010.
- [F2]The number of shares reported includes restricted share units representing the right to receive 2,631 shares of the Issuers common stock that will vest in three equal annual installments beginning April 1, 2011, as detailed in a restricted share unit award agreement by and between the Issuer and the Reporting Person, dated as of September 30, 2009.
- [F3]The option is fully vested and immediately exercisable.
Documents
Issuer
Talecris Biotherapeutics Holdings Corp.
CIK 0001405197
Entity typeother
Related Parties
1- filerCIK 0001472090
Filing Metadata
- Form type
- 4
- Filed
- Dec 1, 7:00 PM ET
- Accepted
- Dec 2, 4:09 PM ET
- Size
- 9.0 KB